Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study
Clicks: 554
ID: 51749
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
76.6
/100
554 views
443 readers
Trending
AI Quality Assessment
Not analyzed
ObjectiveAlthough levothyroxine (LT4) replacement therapy for hypothyroidism has been established as safe, inexpensive and effective, many studies from different countries reported out-of-reference range thyroid-stimulating hormone (TSH) values for the hypothyroid patients under LT4 treatment. The aim of this study was to determine TSH levels of primary hypothyroid patients under LT4 treatment and to assess self-reported compliance with daily LT4 intake in tertiary care centers in Turkey.DesignIn this cross-sectional, observational study, adult patients with primary hypothyroidism, receiving LT4 treatment for at least 6 months, were included. The patients were from 12 tertiary care centers in 9 cities of Turkey. TSH and free T4 levels were recorded from patient files and self-reported compliance with daily LT4 intake was assessed by interviewing the subjects at the last visit.ResultsA total of 1,755 subjects (46 ± 13 years; F/M: 89.9/10.1%) with primary hypothyroidism were enrolled. Of the hypothyroid subjects, 44.8% had out-of-reference range serum TSH levels. TSH values were over the reference range (TSH > 4 mIU/L) in 26.2% and were under the reference range (TSH < 0.5 mIU/L) in 18.6% of the patients. Total duration of LT4 treatment was 5.9 ± 4.7 years and mean dose was 1.2 ± 0.6 μg/kg/day. Non-compliant patients (31.1%) had higher TSH levels (6.9 ± 16 vs 3.8 ± 0.9 mIU/L, P = 0.01) compared to compliant patients.ConclusionThe results of this study revealed that nearly half of the hypothyroid patients had out-of-reference range serum TSH values, despite under LT4 treatment. Compliance with LT4 treatment seems to be one of the major determinants to reach the target TSH levels in hypothyroid patients.
Reference Key |
yavuz2017outofreferencefrontiers
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Yavuz, Dilek Gogas;Yazıcı, Dilek;Keskin, Lezzan;Atmaca, Ayşegül;Sancak, Seda;Saraç, Fulden;Şahin, İbrahim;Dikbaş, Oğuz;Hekimsoy, Zeliha;Yalın, Serap;Uygur, Melin;Yılmaz, Murat;Yirmibeşcik, Sibel;Asmaz, Özlem; |
Journal | Frontiers in endocrinology |
Year | 2017 |
DOI | DOI not found |
URL | |
Keywords |
Nursing
Microbiology
Infectious and parasitic diseases
Medicine
Engineering (General). Civil engineering (General)
Technology
Pediatrics
Science (General)
Science
neurosciences. biological psychiatry. neuropsychiatry
neurology. diseases of the nervous system
gynecology and obstetrics
diseases of the endocrine glands. clinical endocrinology
diseases of the musculoskeletal system
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.